GSK Exclusive Interview Released

Lyophilization USA interviews Drug Product Development Specialist from GSK Vaccines.

Iselin, NJ, July 24, 2017 --(PR.com)-- SMi Group’s next annual Lyophilization USA show is thrilled to welcome Dr. Kelly Forney Stevens, Drug Product Development from GSK Vaccines onto speaker panel for 2017.

Kelly currently works in the Drug Product Development group and is responsible for the development of both the formulation and processing of vaccine drug products. Her research expertise is in lyophilization and solid-state formulations.

A key topic focus in Kelly’s presentation is understanding how and when phase separation occurs. Lyophilization of pharmaceutical proteins is often the only processing method that provides requisite long-term product stability. Freezing and drying, however, can cause acute damage to proteins. While great efforts are placed on developing a formulation and suitable lyophilization cycle, incompatibilities among components through freezing and drying have been almost completely ignored.

Hear more from Kelly at Lyophilization USA when she presents: "Assessing Phase Separation in Lyophilized Protein Formulations." For full presentation details, view the agenda here: www.lyophilization-usa.com/pr3

For those looking to attend there is currently a $100 early-bird saving.
Further information is available at: www.lyophilization-usa.com/pr3

SMi Presents the 3rd Annual Conference on…

Lyophilization USA
Date: November 16th – 17th, 2017
Location: Iselin, New Jersey
Website: www.lyophilization-usa.com/pr3

Sponsored by: Schott | Tempris | W.L. Gore & Associates, Inc

Contact Information:

For all media inquiries contact Pavan Solanki on Tel: +44 (0)20 7827 6048 / Email: psolanki@smi-online.co.uk

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk.
Contact
SMi Group
Pav Solanki
+44 (0) 207 827 6048
http://www.lyophilization-usa.com/pr3
ContactContact
Categories